.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Meta-analyses of randomized trials indicate that low-dose aspirin has the strongest preventive effect against preterm preeclampsia when started in early pregnancy, particularly before 16 weeks. Benefit appears greater in women at high risk, while routine use in low-risk populations is not supported. For clinicians, prevention begins with accurate risk assessment using history and relevant maternal factors. Once aspirin is indicated, adherence and continuation through the recommended gestational window are important. Aspirin should not be used as treatment for established severe preeclampsia and does not replace blood-pressure monitoring, fetal surveillance or timely delivery. The evidence is particularly relevant to first-trimester counselling because the preventive opportunity is time-limited.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
Meta-analyses of randomized trials indicate that low-dose aspirin has the strongest preventive effect against preterm preeclampsia when started in early pregnancy, particularly before 16 weeks. Benefit appears greater in women at high risk, while routine use in low-risk populations is not supported. For clinicians, prevention begins with accurate risk assessment using history and relevant maternal factors. Once aspirin is indicated, adherence and continuation through the recommended gestational window are important. Aspirin should not be used as treatment for established severe preeclampsia and does not replace blood-pressure monitoring, fetal surveillance or timely delivery. The evidence is particularly relevant to first-trimester counselling because the preventive opportunity is time-limited.
Today
The phase 3 ACACIA-HCM trial reveals that aficamten improves cardiac structure, diastolic relaxation, functional capacity, and symptom burden in symptomatic nonobstructive hypertrophic cardiomyopathy, marking a major milestone in targeted myosin inhibition.
6 days back
A clinical study shows that automated breast ultrasound paired with artificial intelligence accurately classifies BIRADS 3-4 lesions, reaching 95% sensitivity and 79% specificity. This diagnostic advance promises to reduce unnecessary core needle biopsies and refine clinical workflows in breast imaging.
3 weeks back
Researchers have engineered freestanding hierarchical-porous BCZT thin films that resist cracking and enhance ultrasonic energy harvesting in soft tissue. Achieving high piezoelectric output and acoustic matching, this lead-free material offers transformative potential for implantable bioelectronics.
Last week
A novel pathology-adaptive surface engineering strategy uses functionalized plasma polymer coatings to selectively modulate AGE adsorption, reducing oxidative stress and restoring bone formation in diabetic and aging microenvironments.
3 weeks back
A breakthrough study identifies the Klotho/PKCα/CUX1/SPARC/TGFβ-RII axis as a critical driver of podocyte mitochondrial injury and ferroptosis in diabetic kidney disease, unveiling promising molecular targets to halt renal disease progression.
6 days back
